Benign Prostatic Hyperplasia Treatment Market Size, Share & Trends Analysis Report By Treatment Type (Pharmacological Treatment (Alpha-blockers, 5-Alpha Reductase Inhibitors, Phosphodiesterase-5 Inhibitors, Others), Minimally Invasive Procedures (Transurethral Resection of the Prostate [TURP], Laser Therapy, Prostatic Urethral Lift [UroLift], Prostatic Artery Embolisation [PAE], Others), Surgical Procedures (Open Prostatectomy, Robotic-Assisted Surgery, Others)), By End-User (Hospitals, Ambulatory Surgical Centers (ASCs), Clinics, Home Care Settings), By Distribution Channel: (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034
Last Updated: May 26, 2026 |
Author: Debashree B |
Format: |
Report Code: SRHI57351DR |
Pages: 155